Genevieve’s Journey: Cannabis and Dentistry for the Developmentally Disabled

Innovative Approaches: Plant Medicine and Dental Experience

To ensure continuity in Genevieve’s plant medicine regimen, innovative approaches like infusing cannabinoids into gelatin-based desserts and soft foods must lead to a positive experience with the dentist she dislikes.

It takes profound amounts of sedation to get her into that dentist chair, and then she must use the gas. She often will also take a nap while the professionals work. THC and CBD were particularly effective for her, whereas CBD initially did not yield the desired results.

Exploring Cannabinoids: THCA, THC, and CBN Regimen for the Developmentally Disabled

Historically, during the initial stages of seizure control and cognitive enhancement, Genevieve primarily benefited from a regimen containing THCA, THC, and CBN housed within an MCT infusion.

This blend preserved the organic plant components, ensured the presence of vital terpenes, and also included flavonoids that are often missing in refined oils. THC and CBN were particularly effective for her, whereas CBD initially did not yield the desired results.

Unveiling the Role of CBGa: A Game-Changing Cannabinoid

This issue led to the incorporation of CBGa, positioning Genevieve as an emblematic case of an autistic child benefiting from this primary acidic cannabinoid common to all cannabis strains.

When we first met, when the Cannabis Love Story family just began in 2016, very few knew what the cannabinoid was, so I had to call it CBG.

She used it for quite some time, and then we slowly backed off, but I kept researching.

Shaping the Future: CBGa Tincture and Genevieve’s Dream

As Genevieve’s metabolic responses evolved and her tolerance to the THC/CBN combination increased, I began to start leveraging insights from my work at the Global Cannabinoid Research Center. I reintroduced CBGa at this time into her regimen.

Embracing Minor Cannabinoids for Holistic Wellness

Recent insights from Oregon State University have illuminated the significance of acidic cannabinoids, notably CBGa, in promoting a deeper understanding of its potential in Cannabis Science.

Many consumers also wanted to know more about it, and our long-lived plan to create Genevieve’s Dream, a CBGa Tincture, began to take root by the sharing of this information our family had discovered.

Cultivating Endocannabinoid Tone: CBG, CBDa, and More

While addressing Genevieve’s body’s saturation from major cannabinoids, the focus shifted towards minor cannabinoids. Innovative solutions, including transdermal delivery mechanisms infused with hemp-derived nanotechnology-crafted minor cannabinoids (CBGa, CBG, CBDa, and others), became pivotal in our journey.

By incorporating these minor cannabinoids into her therapeutic baths, they proved themselves invaluable. They were stimulating endocannabinoid production, which is a critical component for overall system balance when working with cannabis patients.

Research substantiates that consuming minor cannabinoids, coupled with a wholesome diet and physical activity, augments the production of endogenous cannabinoids, which THC emulates.

This facilitates the growth of new CB1 receptors, essential for recalibrating the endocannabinoid system, which is exactly what Genevieve needed.

Individuality Matters: Genevieve’s Unique Cannabinoid Response

The prevalent misconception that CBGa and CBD do not engage with cannabinoid receptors is slowly fading as the world gains more insight into the plant and how it works in the body.

My research findings underscore the role of minor cannabinoids, terpenes, and phytonutrients in significantly enhancing endocannabinoid tone – and found that CBGa as the precursor molecule in the plant is indeed a Major Cannabinoid.

Without CBGa, we would not have THCa, CBCa, CBDa, which all produce quite a few cannabinoids themselves, and of course, CBGa, when heated, makes CBG. The number of this natural propensity amplifies receptor presence, ensuring system balance.

Empowering the Future: Genevieve’s Autonomy with CBGa

With CBGa as the cornerstone, our aspirations for Genevieve’s autonomy get renewed, establishing new milestones for her as previous ones get achieved. The evolving landscape of healthcare indicates a shift towards plant-based treatments, with cases like Genevieve’s exemplifying their efficacy.